Skip to main content
2023 IKCS: North America Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

IND Package and Early Clinical Development

Friday, November 10, 2023
12:13 PM – 12:25 PM CST
Location: Legends ABCD

    Speaker(s)

  • Eric Jonasch, MD

    University of Texas MD Anderson Cancer Center, Texas, United States

    Disclosure(s): Contract Research: Arrowhead Pharmaceuticals (Ongoing); Aveo (Ongoing); Corvus Pharmaceuticals (Ongoing); Merck (Ongoing); NiKang Therapeutics (Ongoing); Telix (Ongoing)
    Non-CE Consulting: Aveo (Ongoing); Eisai (Ongoing); Exelixis (Ongoing); Ipsen (Ongoing); Merck (Ongoing); NiKang Therapeutics (Ongoing); Novartis (Ongoing); Telix (Ongoing)

    Slides
Disclosure(s):
Eric Jonasch, MD: Contract Research: Arrowhead Pharmaceuticals (Ongoing); Aveo (Ongoing); Corvus Pharmaceuticals (Ongoing); Merck (Ongoing); NiKang Therapeutics (Ongoing); Telix (Ongoing)
Non-CE Consulting: Aveo (Ongoing); Eisai (Ongoing); Exelixis (Ongoing); Ipsen (Ongoing); Merck (Ongoing); NiKang Therapeutics (Ongoing); Novartis (Ongoing); Telix (Ongoing)